Lower riskDrug recall · FDA · Published March 10, 2020
Thrive Pharmacy recalls Buprexone Banana cream troche due to subpotent drug
Thrive Pharmacy recalls Buprexone Banana cream 6-0.6 mg troche (Lot 190918B) due to subpotent drug. This may not provide intended medical effect. Consumers should contact Thrive Pharmacy for details.
“Thrive Pharmacy recalls Buprexone Banana cream troche due to subpotent drug.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37336-thrive-pharmacy-recalls-buprexone-banana-cream-troche-due-to-subpotent. Based on FDA recall #D-1052-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1052-2020%22&limit=1).
Thrive Pharmacy recalled Buprexone Banana cream 6-0.6 mg Troche due to subpotent drug risks, the FDA said on March 10, 2020. The voluntary Class II recall involved 71 troches distributed in Florida.
How to tell if you have it
Brand: Thrive Pharmacy
Product: Buprexone Banana cream 6-0.6 mg Troche
Packaging: plastic troche molds with cardboard outer sleeve
Lot code: 190918B
Expiration date: 03/16/2020
Quantity: 71 troches
Distribution area: Florida
The hazard
The recalled Buprexone Banana cream 6-0.6 mg Troche is classified as a subpotent drug, meaning it may not contain the expected strength of active ingredients.
Context
GovInfoNow's records show other recent recalls of similar products include Specialty Process Labs Thyroid Product Recall (2026-01-16), CoValence Laboratories Skin Rehab Gel Recall (2026-03-18), and Unichem busPIRone 5mg Tablets Recall (2026-04-13). These recalls were announced between January 16, 2026, and April 13, 2026.
How to tell if you have this one
Check for the product name 'Buprexone Banana cream 6-0.6 mg Troche' with a plastic troche mold and cardboard outer sleeve. The lot number 190918B was produced at Thrive Pharmacy in Jacksonville, Florida, and expires March 16, 2020.
Brand
Thrive Pharmacy
Category
Drug
FDA recall event · 3 products
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
Classification
Class II
Status
Terminated
Distribution
Florida
Recall number
Product, codes & lots
Quantity
D-1052-2020
Buprexone Banana cream 6-0.6 mg Troche, supplied in plastic troche molds with cardboard outer sleeve, Thrive Pharmacy 2863 St Johns Bluff RD. South # 135 Jacksonville, Florida; Lot: 190918B Exp. 03/16/2020
71 troches
D-1053-2020
Buprenorphine Watermelon 8 mg Troche, supplied in plastic troche molds with cardboard outer sleeve, Thrive Pharmacy 2863 St Johns Bluff RD. South # 135 Jacksonville, Florida; Lot: 191203F Exp. 05/31/2020
403 troches
D-1054-2020
Buprenorphine Black Cherry 2 mg Troche, supplied in plastic troche molds with cardboard outer sleeve, Thrive Pharmacy 2863 St Johns Bluff RD. South # 135 Jacksonville, Florida; Lot: 191217A Exp. 06/14/2020
89 troches
Based on the official FDA remedy
What to do — step by step
Contact Thrive Pharmacy
Reach out to Thrive Pharmacy at 2863 St Johns Bluff RD, South #135 Jacksonville, Florida for specific instructions on the recall.
Where it went and when
Where it was distributed
Distributed in Florida.
Listed by the agency
Not listed
FDA distribution: “Florida” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Florida.
Recall timeline
FDA terminated this recall 3.2 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The product may be subpotent, meaning it might not provide the intended medical effect. It is not safe to use if it does not meet the required potency standards.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1052-2020 (March 10, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1052-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.